Genetic testing for Hereditary pheochromocytoma/ paraganglioma syndrome(HPPS)

Genetic testing for Hereditary pheochromocytoma/ paraganglioma syndrome(HPPS) - Evaluation of genetic testing for HPPS

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000010034

Enrollment

900

Registered

2013-02-15

Start date

2007-07-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pheochromocytoma and Paraganglioma Index case Asymptomatic carrier(first relative degrees)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Index case of HPPS, especially, paraganglioma(extra adrenal)and/or younger than 30years old, malignancy, recurrence, bilatelal,familial. Asymptomatic carrier (first relative degrees )

Exclusion criteria

Exclusion criteria: under 16 years old

Design outcomes

Primary

Measure	Time frame
Efficasy for genetic testing for HPPS	—

Countries

Japan

Contacts

Public ContactKazuhiro Takekoshi

University of Tsukuba Faculty of Medicine

K-takemd@md.tsukuba.ac.jp029-853-3389

Outcome results